Arterial bypass iterative thrombosis and cancer: Three cases;Thromboses itératives de pontages artériels et cancer: À propos de trois cas

Journal des Maladies Vasculaires

Volumn 39, Issue 1, 2014, Pages 14-17

  Villemur, B ^a   Payraud, E ^a   Seetha, V ^a   De Angelis, M P ^a   Magne, J L ^a   Perennou, D ^a   Carpentier, P ^a   Pernod, G ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Arterial bypass thrombosis; Cancer; Ischemic events; Peripheral arterial disease

Indexed keywords

ARTERIAL BYPASS THROMBOSIS; CANCER; ISCHEMIC EVENTS; ISCHÉMIE AIGUË; PERIPHERAL ARTERIAL DISEASE; PONTAGE; THROMBOSES ARTÉRIELLES;

AGED; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; CARCINOMA, HEPATOCELLULAR; CAUSALITY; COMBINED MODALITY THERAPY; COMORBIDITY; DISEASE SUSCEPTIBILITY; HUMANS; HYPERTENSION; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; PERIPHERAL ARTERIAL DISEASE; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RISK FACTORS; SMOKING; THROMBOPHILIA; THROMBOSIS; URINARY BLADDER NEOPLASMS; VASCULAR SURGICAL PROCEDURES;

EID: 84895073313     PISSN: 03980499     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmv.2013.09.003     Document Type: Article

References (24)

1. Blom J.W., Doggen C.J.M., Osanto S., Rosendaal F.R. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005, 293:715-722.
2. Nehler M.R., Krupski W.C. Cardiac complications and screening. Vascular Surgery, vol. 1 2000, 626-646. WB Sanders, Philadelphia. 5th ed. R.B. Rutherford (Ed.).
3. Bergan J.J., Wilson S.E., Wolf G., Deupree R.H. Unexpected late cardiovascular effects of surgery for peripheral artery disease. Veterans Affairs Cooperative Study 199. Arch Surg 1992, 127:1119-1123.
4. Khorana A.A., Francis C.W., Culakova E., Fisher R.I., Kuderer N.M., Lyman G.H. Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 2006, 24:484-490.
5. Khorana A.A., Francis C.W., Blumberg N., Culakova E., Refaai M.A., Lyman G.H. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med 2008, 168:2377-2381.
6. El Sakka K., Gambhir R.P.S., Halawa M., Chong P., Rashid H. Association of malignant disease with critical leg ischaemia. Br J Surg 2005, 92:1498-1501.
7. Javid M., Magee T.R., Galland R.B. Arterial thrombosis associated with malignant disease. Eur J Vasc Endovasc Surg 2008, 35:84-87.
8. Schattner A., Klepfish A., Huszar M., Shani A. Two patients with arterial thromboembolism among 311patients with adenocarcinoma of the pancreas. Am J Med Sci 2002, 324:335-338.
9. Thomas R.H. Hypercoagulability syndromes. Arch Intern Med 2001, 161:2433-2439.
10. Kwaan H.C.M.D., Parmar S., Wang J. Pathogenesis of increased risk of thrombosis in cancer. Semin Thromb Hemost 2003, 29:283-290.
11. Varki A. Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood 2007, 110:1723-1729.
12. Bevilacqua M.P., Pober J.S., Majeau G.R., Fiers W., Cotran R.S., Gimbrone M.A. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci U S A 1986, 83:4533-4537.
13. Contrino J., Hair G., Kreutzer D.L., Rickles F.R. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 1996, 2:209-215.
14. Zuckerman E., Toubi E., Golan T.D., et Rosenvald-Zuckerman T., Sabo E., Shmuel Z., et al. Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy. Br J Cancer 1995, 72:447-451.
15. Schwarzbach C.J., Schaefer A., Ebert A., Held V., Bolognese M., Kablau M., et al. Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology. Stroke 2012, 43:3029-3034.
16. Sanon S., Lenihan J., Mouhayar E. Peripheral arterial ischemic events in cancer patients. Vasc Med 2011, 16:119-130.
17. Dutta T., Karas M.G., Segal A.Z., Kizer J.R. Yield of transesophageal echocardiography for nonbacterial thrombotic endocarditis and other cardiac sources of embolism in cancer patients with cerebral ischemia. Am J Cardiol 2006, 97:894-898.
18. Iguchi Y., Kimura K., Kobayashi K., Ueno Y., Inoue T. Ischaemic stroke with malignancy may often be caused by paradoxical embolism. J Neurol Neurosurg Psychiatry 2006, 77:1336-1339.
19. Jurado J.A., Bashir R., Burket M.W. Radiation-induced peripheral artery disease. Catheter Cardiovasc Interv 2008, 72:563-568.
20. Gladding P.A., Webster M.W., Kay P. Late drug-eluting stent thrombosis and erythropoietin: cause and effect?. Heart Lung Circ 2007, 16:305-307.
21. De Stefano V., Sorà F., Rossi E., Chiusolo P., Laurenti L., Fianchi L., et al. The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost 2005, 3:1985-1992.
22. Landolfi R., Di Gennaro L., Falanga A. Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation. Leukemia 2008, 22:2020-2028.
23. Gruppo Italiano Studio, Policitemia Polycythemia vera: the natural history of 1213patients followed for 20years. Ann Intern Med 1995, 123:656-664.
24. Lassila R. Role and management of coagulation disorders in peripheral arterial disease. Scand J Surg 2012, 101:94-99.